These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29377371)

  • 1. Progeria: case report and new drugs perspectives.
    Grana AG; Silva AA; Moura Filho FR; Rodrigues Ferreira Rocha de Alencar R; Chicre Bandeira de Melo P
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e293-e294. PubMed ID: 29377371
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine. Drug trial offers uncertain start in race to save children with progeria.
    Couzin-Frankel J
    Science; 2012 Sep; 337(6102):1594-5. PubMed ID: 23019622
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicine. Mouse study suggests cancer drugs could help prematurely aging kids.
    Travis J
    Science; 2006 Feb; 311(5763):934-5. PubMed ID: 16484462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemical inhibition of NAT10 corrects defects of laminopathic cells].
    Larrieu D; Rodriguez R; Britton S
    Med Sci (Paris); 2014; 30(8-9):745-7. PubMed ID: 25174749
    [No Abstract]   [Full Text] [Related]  

  • 5. Lamin A-linked progerias: is farnesylation the be all and end all?
    Smallwood DT; Shackleton S
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):281-6. PubMed ID: 20074075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progeria, the nucleolus and farnesyltransferase inhibitors.
    Mehta IS; Bridger JM; Kill IR
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):287-91. PubMed ID: 20074076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
    Glynn MW; Glover TW
    Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progeria and the early aging in children: a case report.
    Carvalho VO; Celli A; Bancke Laverde BL; Cunico C; Santos Piedade G; Lucas de Mello M; Beirao Junior PS
    Dermatol Online J; 2016 Feb; 22(2):. PubMed ID: 27267192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
    Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug development for progeria yields insights into normal aging.
    Jiang K
    Nat Med; 2013 May; 19(5):515. PubMed ID: 23652088
    [No Abstract]   [Full Text] [Related]  

  • 11. New approaches to progeria.
    Kieran MW; Gordon L; Kleinman M
    Pediatrics; 2007 Oct; 120(4):834-41. PubMed ID: 17908771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lonafarnib for cancer and progeria.
    Wong NS; Morse MA
    Expert Opin Investig Drugs; 2012 Jul; 21(7):1043-55. PubMed ID: 22620979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome.
    Gordon LB; Kleinman ME; Miller DT; Neuberg DS; Giobbie-Hurder A; Gerhard-Herman M; Smoot LB; Gordon CM; Cleveland R; Snyder BD; Fligor B; Bishop WR; Statkevich P; Regen A; Sonis A; Riley S; Ploski C; Correia A; Quinn N; Ullrich NJ; Nazarian A; Liang MG; Huh SY; Schwartzman A; Kieran MW
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16666-71. PubMed ID: 23012407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
    McClintock D; Gordon LB; Djabali K
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laminopathies; Mutations on single gene and various human genetic diseases.
    Kang SM; Yoon MH; Park BJ
    BMB Rep; 2018 Jul; 51(7):327-337. PubMed ID: 29764566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progeria: a paradigm for translational medicine.
    Gordon LB; Rothman FG; López-Otín C; Misteli T
    Cell; 2014 Jan; 156(3):400-7. PubMed ID: 24485450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanics in human fibroblasts and progeria: Lamin A mutation E145K results in stiffening of nuclei.
    Apte K; Stick R; Radmacher M
    J Mol Recognit; 2017 Feb; 30(2):. PubMed ID: 27677907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting protein prenylation in progeria.
    Young SG; Yang SH; Davies BS; Jung HJ; Fong LG
    Sci Transl Med; 2013 Feb; 5(171):171ps3. PubMed ID: 23390246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progeria: a rare genetic premature ageing disorder.
    Sinha JK; Ghosh S; Raghunath M
    Indian J Med Res; 2014 May; 139(5):667-74. PubMed ID: 25027075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome.
    Gordon LB; Shappell H; Massaro J; D'Agostino RB; Brazier J; Campbell SE; Kleinman ME; Kieran MW
    JAMA; 2018 Apr; 319(16):1687-1695. PubMed ID: 29710166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.